Chala Workisa, Adamu Kasaye, Mohammed Hawa, Deresse Getaw, Tesfaye Shimelis, Gelaye Esayas
National Veterinary Institute, P.O. Box 19, Bishoftu, Ethiopia.
College of Veterinary Medicine and Agriculture Addis Ababa University, P.O. Box 34, Bishoftu, Ethiopia.
Vet Med Int. 2024 Aug 16;2024:6038724. doi: 10.1155/2024/6038724. eCollection 2024.
Lumpy skin disease (LSD) is an economically significant viral disease because of its high morbidity and high production loss. Vaccination of cattle using LSD vaccines is a more effective disease preventive and control strategy in endemic countries such as Ethiopia. Despite high vaccination coverage, there is an increasing number of field reports of the disease outbreaks. Thus, an observational study was designed to investigate disease, characterize the disease-causing agent, and isolate the virus from a local isolate for future vaccine development. Wera Jarso and Amuru districts in North West Oromia were chosen based on outbreak occurrence. For this study skin, 13 pooled biopsy samples were collected from affected cattle. In this outbreak investigation, the morbidity rate was 6.50%, the mortality rate was 0.50%, and the case fatality rate was 7.77%. The virus was isolated from all skin samples on both lamb testis and lamb kidney primary cells and confirmed to be LSDV using conventional and real-time PCR genotyping. Therefore, after each suspected LSD outbreak, a molecular test should be carried out to confirm the cause of the disease, targeting the previously suggested RPO30 or GPCR genes. Further studies targeting more regions and outbreaks, including full genome sequencing to check for genetic differences between the field viruses and vaccine strains, are recommended.
结节性皮肤病(LSD)是一种具有重大经济影响的病毒性疾病,因其发病率高且造成巨大的生产损失。在埃塞俄比亚等流行国家,使用LSD疫苗给牛接种疫苗是一种更有效的疾病预防和控制策略。尽管疫苗接种覆盖率很高,但关于疾病暴发的现场报告却越来越多。因此,设计了一项观察性研究,以调查该疾病、鉴定致病因子,并从本地分离株中分离病毒,用于未来疫苗的研发。根据疫情发生情况,选择了奥罗米亚西北部的韦拉贾尔索和阿穆鲁地区。在本研究中,从患病牛身上采集了13份合并的皮肤活检样本。在这次疫情调查中,发病率为6.50%,死亡率为0.50%,病死率为7.77%。在羔羊睾丸和羔羊肾原代细胞上,从所有皮肤样本中分离出病毒,并使用常规和实时PCR基因分型法确认为LSD病毒。因此,在每次疑似LSD疫情暴发后,应进行分子检测以确认病因,检测靶点为之前建议的RPO30或GPCR基因。建议针对更多地区和疫情进行进一步研究,包括全基因组测序,以检查野外病毒和疫苗株之间的基因差异。